Clinical protocols, member stories, and plain-language science from the Meto care team. We publish what we'd want to read if we were figuring this out for the first time

Semaglutide patent expiry biosimilar competition is arriving — but not equally everywhere. This explainer breaks down the US vs. global timeline, what the FDA's tentative generic approval means, why compounded semaglutide is no longer legal, and what cost-conscious GLP-1 users should do right now.

Gut brain axis peptides BPC-157 and KPV are emerging at the intersection of gut inflammation and neurological health. This deep dive covers how each peptide acts on the gut-brain connection, what the research shows, and what a clinical assessment looks like.